Skip to content
Loading...
Loading...
Media
Careers
Contact
en
sv
Search
Search for:
Search
Search
Search for:
Search
en
sv
Menu
en
sv
About Us
About Us
Management Team
Board of Directors
Our History
Grants
Our Science
Our Science
Pipeline
Setanaxib
Presentations & Publications
Our Products
Partnerships
Patients
Patients
Managing igA Nephropathy
Current Clinical Trials
Expanding Access to TARPEYO
Investors
Investors
Invest in Calliditas
The Share
Trading Information
Ownership Structure
Share Capital Development
Dividend Policy
Analyst Coverage
Financial Reports and Presentations
SEC Filings
Press Releases
Calendar
Investor FAQs
Contact
Governance
Governance
Corporate Governance Reports
General Meeting
Annual general meeting 2023
General Meetings
Nomination Committee
Nomination Committees
Board and Committees
Board of Directors
Board Fees
Work of the Board of Directors
Committees
Management
Management Team
Remuneration
Internal Control & Risk Management
Auditor
Articles of Association
Media
Careers
Contact
Financial Reports and Presentations
2023
All years
2023
2022
2021
2020
2019
2018
2017
Type of information
All types
Annual reports
Company presentations
Interim reports
Webinars
Report
Presentation
Webcast
November, 2023
Financial Times Event, London, November 2023
November, 2023
Corporate Presentation
November 7, 2023
Interim Report Q3 2023
August 17, 2023
Interim Report Q2 2023
June 16, 2023
European Renal Association (ERA) Congress 2023
May 16, 2023
Interim Report Q1 2023
April 26, 2023
Annual Report 2022
March 13, 2023
NefIgArd topline data - presentation
February 23, 2023
Year-end report 2022
